Vivapharma SRL
Vivapharma reported total assets of 236,296 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026).
The score of Vivapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +47 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vivapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 118,241 € | ||||
| Equity | 126,780 € | ||||
| Cash | 102,103 € | ||||
| EBITDA | 171,856 € | ||||
| Total assets | 236,296 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
Vivapharma's financial analysis
- Solvency53.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vivapharma
Vivapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0740.481.964
- VAT number
- BE0740481964
- Peppol
- Registered · 0208:0740481964 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Dec 2019
- Registered office
- 1160 Auderghem
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Vivapharma (SRL) has been based in Auderghem since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 118,241 € and equity of 126,780 €; its revenue is not published. Its solvency stands at 53.7%, above the median of its sector (37.8%).
Companies similar to Vivapharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Hankar Retail sale of pharmaceutical products Auderghem · balance sheet 205,159 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
- Ptms Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
- Apotheek VAN Dionant Retail sale of pharmaceutical products Beersel · balance sheet 229,148 €
- LUC Thaens Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 204,672 €
- Walpharma Retail sale of pharmaceutical products Arlon · balance sheet 202,753 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
- Somad Retail sale of pharmaceutical products Frameries · balance sheet 170,686 €
Frequently asked questions about Vivapharma
What is the revenue of Vivapharma?
Vivapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vivapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0740481964 for Vivapharma, if the company is VAT-registered. Its company number (CBE) is 0740.481.964.
Where is the registered office of Vivapharma?
According to the CBE register, the registered office of Vivapharma is in 1160 Auderghem.
What is the equity of Vivapharma?
At the close of the 2025 financial year, the equity of Vivapharma amounts to 126,780 €, a solvency of 53.7% of total assets.
Who manages Vivapharma?
The register lists 2 active mandates at Vivapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vivapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →